titanium dioxide has been researched along with Fibrosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aledavood, SA; Bakhshizadeh, M; Esmaily, H; Hadizadeh, F; Mohajeri, SA; Sazgarnia, A; Seifi, M; Varshoei Tabrizi, F | 1 |
Fujii, J; Iigo, M; Kobayashi, M; Ogawara, S; Okada, F; Onuma, K; Sato, Y; Shirasawa, N; Yoshimura, T; Yoshitake, J | 1 |
2 other study(ies) available for titanium dioxide and Fibrosarcoma
Article | Year |
---|---|
Utilizing photosensitizing and radiosensitizing properties of TiO
Topics: Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Dose-Response Relationship, Drug; Fibrosarcoma; Humans; Hydroxyl Radical; Melanoma; Mitoxantrone; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Radiation-Sensitizing Agents; Titanium | 2019 |
Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytokines; Deoxyguanosine; Dinoprostone; Female; Fibrosarcoma; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasm Invasiveness; Particle Size; Reactive Oxygen Species; Thymosin; Titanium; Vascular Endothelial Growth Factor A | 2009 |